Evaluation of histological staging systems for primary biliary cirrhosis: Correlation with clinical and biochemical factors and significance of pathological parameters in prognostication

Histopathology

Volumn 65, Issue 2, 2014, Pages 174-186

  Chan, Anthony W H ^a   Chan, Ronald C K ^b   Wong, Grace L H ^c   Wong, Vincent W S ^c   Choi, Paul C L ^a   Chan, Henry L Y ^c   To, Ka Fai ^a,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Child Pugh score; Copper associated protein; Ludwig stage; Mayo risk score; MELD score; Scheuer stage

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN; CREATININE; MITOCHONDRION ANTIBODY; SERUM ALBUMIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD PUGH SCORE; CLINICAL EFFECTIVENESS; CORE BIOPSY NEEDLE; CREATININE BLOOD LEVEL; END STAGE LIVER DISEASE; EVALUATION STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; LIVER BIOPSY; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MODEL FOR END STAGE LIVER DISEASE SCORE; PERCUTANEOUS BIOPSY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; STAGING; VERY ELDERLY; BILIARY CIRRHOSIS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84904391356     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12384     Document Type: Article

References (23)

1. Lindor KD, Gershwin ME, Poupon R et al. Primary biliary cirrhosis. Hepatology 2009; 50; 291-308.
2. Kuiper EM, Hansen BE, de Vries RA et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology 2009; 136; 1281-1287.
3. Zhao DT, Liao HY, Liu YM, Zhao Y, Feng X, Yan HP. Prognostic factors and survival analysis of antimitochondrial antibody-positive primary biliary cirrhosis in Chinese patients. Dig. Dis. Sci. 2011; 56; 2750-2757.
4. Zhang LN, Shi TY, Shi XH et al. Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort study. Hepatology 2013; 58; 264-272.
5. Wong GL, Hui AY, Wong VW, Chan FK, Sung JJ, Chan HL. A retrospective study on clinical features and prognostic factors of biopsy-proven primary biliary cirrhosis in Chinese patients. Am. J. Gastroenterol. 2005; 100; 2205-2211.
6. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989; 10; 1-7.
7. Murtaugh PA, Dickson ER, Van Dam GM et al. Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. Hepatology 1994; 20; 126-134.
8. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33; 464-470.
9. Rubin E, Schaffner F, Popper H. Primary biliary cirrhosis. Chronic non-suppurative destructive cholangitis. Am. J. Pathol. 1965; 46; 387-407.
10. Scheuer P. Primary biliary cirrhosis. Proc. R. Soc. Med. 1967; 60; 1257-1260.
11. Popper H, Schaffner F. Nonsuppurative destructive chronic cholangitis and chronic hepatitis. Prog. Liver Dis. 1970; 3; 336-354.
12. Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch. A Pathol. Anat. Histol. 1978; 379; 103-112.
13. Hiramatsu K, Aoyama H, Zen Y, Aishima S, Kitagawa S, Nakanuma Y. Proposal of a new staging and grading system of the liver for primary biliary cirrhosis. Histopathology 2006; 49; 466-478.
14. Nakanuma Y, Zen Y, Harada K et al. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: interobserver agreement. Pathol. Int. 2010; 60; 167-174.
15. Angulo P, Lindor KD, Therneau TM et al. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver 1999; 19; 115-121.
16. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J. Hepatol. 2009; 51; 237-267.
17. Kakuda Y, Harada K, Sawada-Kitamura S et al. Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems. Hum. Pathol. 2013; 44; 1107-1117.
18. Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N. Engl. J. Med. 1983; 308; 1-7.
19. Westin J, Lagging LM, Wejstal R, Norkrans G, Dhillon AP. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 1999; 19; 183-187.
20. Juluri R, Vuppalanchi R, Olson J et al. Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease. J. Clin. Gastroenterol. 2011; 45; 55-58.
21. Crawford AR, Lin XZ, Crawford JM. The normal adult human liver biopsy: a quantitative reference standard. Hepatology 1998; 28; 323-331.
22. Chazouillères O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998; 28; 296-301.
23. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin. Liver Dis. 2004; 24; 89-97.